Many investors were on edge this weekend after the stock market
plummeted on Thursday due to China’s faltering stock market and concerns
that the Fed will raise interest rates. Consequently, the Dow fell by
500 points, undoing the progress it had made all year. Despite the
volatility, activity on Wall Street must go on. Although earnings season
is coming to a close, there are still a handful of companies reporting
earnings this week along with several biotechnology companies awaiting
drug approvals. Here is what to look for in
Seadrill Ltd (NYSE:
SDRL),
Sarepta Therapeutics Inc (NASDAQ:
SRPT), and
Amgen, Inc. (NASDAQ:
AMGN)
Seadrill Ltd
Oil giant Seadrill Ltd is slated to announce second quarter 2015
earnings results on Thursday, August 27, after market close. The Street
expects the company to post earnings of $0.63 per share on $1.18 billion
in revenue, falling from $0.70 earnings per share on $1.22 billion in
revenue year-over-year.
(more)
No comments:
Post a Comment